Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07632183 · ClinicalTrials.gov registry record · NA

Will a Hands on Technique Applied to the Face Increase the Tear Production in Participants

A NA study, sponsored by Edward Via Virginia College of Osteopathic Medicine.

Active
Registry status
NA
Development phase
30
Enrollment target

NCT07632183: Active NA study, sponsored by Edward Via Virginia College of Osteopathic Medicine.

NCT07632183 is a NA study that is active but no longer recruiting, run by Edward Via Virginia College of Osteopathic Medicine. The registered enrollment target is 30 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07632183, a NA study, is active but no longer recruiting, sponsored by Edward Via Virginia College of Osteopathic Medicine.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target

Study Summary

The goal of this interventional study is to learn if a hands on technique will increase tear production in patients aged 45 and younger, without a history of eye issues. The main question it aims to answer is: Will there be an increase in tear production using a specific hand on technique applied inside the mouth? Participants will have a small, sterile, piece of paper that will be placed briefly in their eye. This is done to take measurements of tear production. A doctor will then perform a hands on technique in which a gloved finger is placed in the participants' mouth to release the tension that is found. After the technique is completed, the participants' eye will be retested with the tear strip. The tear test strip will be applied twice more on the following visits at 2 days after the first session and one week after the first session

Primary Outcome

Will measure tear production via the Schirmer test strips and will compare pre and post intervention

Interventions

  • PROCEDURE sphenopalatine ganglion release

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2024-10-08
Est. Completion 2027-06
Phase NA

What the registry record for NCT07632183 still lists

NCT07632183 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 1 intervention - of which sphenopalatine ganglion release is the first listed.

NCT07632183 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT07632183 about?

NCT07632183 is a clinical study titled "Will a Hands on Technique Applied to the Face Increase the Tear Production in Participants". The goal of this interventional study is to learn if a hands on technique will increase tear production in patients aged 45 and younger, without a history of eye issues. The main question it aims to answer is: Will there be an increase in tear production using a specific hand on technique applied i...

What is the current status of trial NCT07632183?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2024-10-08. Estimated completion is 2027-06.

What interventions are being tested in trial NCT07632183?

The interventions under investigation include: sphenopalatine ganglion release (PROCEDURE).

Who is sponsoring clinical trial NCT07632183?

This trial is sponsored by Edward Via Virginia College of Osteopathic Medicine, which has 19 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT07632183's enrollment target sits among peer trials

30 1593rd of 2000 higher than 299 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00977977 · 30 participants · Phase 2

    Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

  • NCT01459107 · 30 participants · Phase 2

    Human Upper Extremity Allotransplantation

  • NCT01666080 · 30 participants · NA

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

  • NCT01720836 · 30 participants · Phase 1

    Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07632183, the US trial registry maintained by the National Library of Medicine. NCT07632183 (small enrollment · none site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.